Osteoporosis is a multifactorial disorder characterized by low bone mass and strength, leading to increased risk of fracture. The WNT pathway plays a critical role in bone remodeling by enhancing osteoblastic differentiation, which promotes bone formation, and inhibiting osteoclastic differentiation, decreasing bone resorption. Therefore, genetic alterations of this pathway will lead to impaired bone homeostasis and could contribute to varying response to treatment. We present the case of two brothers with early osteoporosis who were found to have a heterozygous variant of unknown significance in the gene, c.1060_1061delCAinsG (p.H354Afs*39). This finding demonstrates that frameshift variants in may also act in a dominant fashion leading to decreased bone mass.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8379666 | PMC |
http://dx.doi.org/10.1016/j.bonr.2021.101118 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!